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Helicobacter pylori is a widely prevalent microbe, Epidemiological and experimental data pointed recently to a strong relation of
H. pylori infection on the development of many extragastric diseases, including several allergic and autoimmune diseases. We report
a 65-year-old man who presented with cutaneous vasculitis accompanied by gastric H. pylori (Hp) infection. The gastro intestinal
manifestations and purpuric lesions were dramatically resolved after Hp eradication therapy.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Helicobacter pylori (HP) is a Gram-negative bacterium
that has been linked to peptic ulcer disease, gastric lym-
phoma, and gastric carcinoma. Recently, several reports
have been pointing to a possible relationship between
H. pylori infection of gastric mucosa and vasculitis. Associ-
ation has been reported for urticaria, Behc¸et’s disease and
Henoch–Schonlein purpura. We report a 65-year-old man
who presented with vascular purpura accompanied by gas-
tric infection. The gastro intestinal manifestations and
purpuric lesions were dramatically resolved after HP
eradication therapy. To date, very few publications have
focused on the possible pathogenetic relationship between
Hp infection and cutaneous vasculitis.http://dx.doi.org/10.1016/j.jdds.2015.12.001
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A 65-year-old man, without notable medical history was
admitted for vascular purpura, arthralgia and epigastralgia
lasting for 2 weeks before admission. There was no history
of fever, vomiting, hematemesis, melena, diarrhea, consti-
pation or weight loss. Physical examination showed blood
pressure of 150/90 mmHg. An extensive vascular purpura
was observed with purpuric lesions of diﬀerent ages in
the legs, thighs and forearms (Figs. 1 and 2). There was
no arthritis. Cardiopulmonary, abdominal and neurologi-
cal examinations were normal.
The white blood cell count was 7200/mm3 without lym-
phopenia and the hemoglobin level was 14.4 g/dl. Inﬂamma-
tory indices, creatinine level and liver functionwere normals.
Serum electrophoresis and ponderal dosage of immunoglob-
ulins were without abnormalities. Hepatitis B, hepatitis C,
CMV, Syphilis and HIV serologies were negative. Immuno-
logical tests including Anti nuclear antibodies (AAN), anti
DNAn, ANCA and Cryoglobulinemia were negative.
Skin biopsy was performed and objectived an epidermis
slightly modiﬁed, a dermal inﬂammatory inﬁltratebehalf of King Saud University.
ommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Vascular purpura in the forearms.
Figure 2. Vascular purpura in the legs.
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around capillaries without free parietal lesions. Extravasa-
tion of red blood cells was noted. Direct immunoﬂuores-
cence performed showed irregular microgranular deposits
of immunoglobulins at the dermo-epidermal junction.
Esogastroduodenal ﬁbroscopy was performed because
of epigastralgia and objectived antral, congestive and
nodular gastritis with three bulbar ulcerations. Antral
mucosa biopsy showed follicular chronic interstitial gastri-
tis moderately active and positive HP.
On the ﬁrst day of his admission, the treatment was
based on empiric antibiotic therapy but the evolution was
marked by the extension of purpura on the anterior surface
of the trunk and face. Corticosteroid therapy was therefore
indicated without improvement. The eradication therapy of
the HP infection was accompanied by a dramatical resolu-
tion of the purpura.3. Discussion
HP is a gram negative spiral shaped bacillus and a major
etiological agent in the causation of gastritis and ulcerdisease (Rook et al., 2006) and also of many extra gastric
manifestations. Various mechanisms have been proposed
to explain the extra intestinal autoimmune manifestations
of H. pylori infections. The inﬂammatory response to
H. pylori infection can lead to the development of antigen–
antibody complexes or cross-reactive antibodies resulting
in autoimmunity (Uemura et al., 2001).
There has been some evidence of an association of
H. pylori infection with various vasculitis especially
Henoch–Schonlein purpura (HSP) and Behc¸et’s disease
(BD).
HSP is a leukocytoclastic vasculitis of small vessels
involving the skin, joints, gastro-intestinal tract and kid-
neys. The pathogenesis of HSP remains unclear. Many
conditions such as bacterial or viral infections, vaccinations
and drugs may be responsible for the onset. Hoshino (2009)
reported a 33-year-old man with HSP accompanied by gas-
tric HP infection. The gastro-intestinal manifestations and
purpuric rashes were resolved after HP eradication ther-
apy. Mytinger et al. (2008) reported a 13-year-old boy with
HSP associated with HP infection. Several other cases were
reported (Machet et al., 1997; Shin et al., 2009). Treatment
of the HP infection was accompanied by the resolution of
the HSP.
Behc¸et’s disease (BD) is a vasculitis characterized by
recurrent oral aphthous ulcers, genital ulcers, uveitis, and
skin lesions. Its association with HP infection has been
described. A genetic susceptibility for both BD and
H. pylori infection has been implicated by the fact that
H. pylori infection is endemic in most of the countries in
which BD is also highly prevalent (Avci et al., 1999;
Ersoy et al., 2007). But more trials are necessary to check
the association between H. pylori and BD.
An association between HP and cutaneous vasculitis is
exceptional. The possible mechanism in causation is still
less understood. One of the suggested pathogenic mecha-
nisms is that infection with HP may induce the production
of pathogenetic antibodies, possibly, by molecular mimicry
(Leontiadis et al., 1999; Ben Mahmoud et al., 2011). HP
infection might be a source of circulating immune com-
plexes and these immune complexes may trigger cutaneous
vasculitis. Gastric colonization by HP is accompanied by
the production of large quantities of various proinﬂamma-
tory substances. This inﬂammatory response may lead to
the development of antigen–antibody complexes or cross-
reactive antibodies (by molecular mimicry) resulting in
damage to other organs (Kutlubay et al., 2014).
In general, the relationship of HP infection and cuta-
neous vasculitis may be underestimated. In our patient,
the relationship was retained after eliminating other infec-
tions and autoimmune diseases. Endoscopic ﬁndings with
histopathology are the main stay of diagnosis for H. pylori
as in our patient endoscopy with biopsy conﬁrmed
H. pylori infection.
Corticosteroids are useless. The treatment is based on
eradication HP. The evolution in our case was dramatically
favorable.
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This case report represents H. pylori as a possible etio-
logical agent of cutaneous vasculitis. The implications of
such associations are important to be known given the
therapeutic problems they raise. Randomized controlled
trials are necessary to conﬁrm this relationship and to
evaluate the usefulness of H. pylori eradication therapy.
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